Profil
Michael Pepper is the founder of Antion Biosciences SA. He currently holds a position as a Member-Supervisory Board at Raiffeisenbank Aschaffenburg eG.
Postes actifs de Michael Pepper
| Sociétés | Poste | Début |
|---|---|---|
Raiffeisenbank Aschaffenburg eG
 Raiffeisenbank Aschaffenburg eG Regional BanksFinance Raiffeisenbank Aschaffenburg eG operates as a state chartered commercial bank. The private company is based in Aschaffenburg, Germany. and has subsidiaries in Germany. The German company was founded in 1878. The CEO is Claus Jäger. | Directeur/Membre du Conseil | - |
Antion Biosciences SA
 Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Raiffeisenbank Aschaffenburg eG
Raiffeisenbank Aschaffenburg eG Regional BanksFinance Raiffeisenbank Aschaffenburg eG operates as a state chartered commercial bank. The private company is based in Aschaffenburg, Germany. and has subsidiaries in Germany. The German company was founded in 1878. The CEO is Claus Jäger. | Finance |
Antion Biosciences SA
Antion Biosciences SA BiotechnologyHealth Technology Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini. | Health Technology |
